Glutathione synthesis and redox system (GSH system)

The glutathione synthesis and redox system is a fundamental cellular defense network responsible for maintaining redox homeostasis and protecting cells from oxidative and electrophilic stress (Amerigo Scientific; NIH, 2013). It centers on the tripeptide glutathione (GSH), which is synthesized in two ATP-dependent steps catalyzed by glutamate-cysteine ligase (GCL) and glutathione synthetase (GSS) (NIH, 2013; Frontiers, 2013). The system operates through a continuous redox cycle where glutathione peroxidase (GPx) uses GSH to neutralize reactive oxygen species, producing oxidized glutathione (GSSG), which is then recycled back to GSH by glutathione reductase (GR) using NADPH (Amerigo Scientific; NIH, 2005). Beyond its antioxidant role, the system is critical for the detoxification of xenobiotics via glutathione S-transferases (GSTs) and regulates key processes like apoptosis, ferroptosis, and immune function (NIH, 2013; ResearchGate, 2023). Dysregulation of this system is implicated in numerous pathologies, including cancer, where elevated GSH levels contribute to chemoresistance, and neurodegenerative diseases like Parkinson's, where GSH depletion exacerbates oxidative damage (ResearchGate, 2023; NIH, 2017). Therapeutic strategies include supplementing GSH precursors like N-acetylcysteine to treat toxicity, inhibiting synthesis with buthionine sulfoximine to sensitize tumors, or inducing the system via Nrf2 activators to combat chronic inflammation (ResearchGate, 2023; NIH, 2013).

Other names

Glutathione metabolic pathwayGlutathione redox cycleGSH homeostasis systemGamma-glutamyl cycle

The system is modulated through several mechanisms: providing biosynthetic precursors like N-acetylcysteine to increase GSH levels, inhibiting rate-limiting enzymes such as glutamate-cysteine ligase with buthionine sulfoximine, mimicking antioxidant enzymes like glutathione peroxidase with ebselen, inhibiting cystine transporters to induce ferroptosis with erastin, or transcriptionally upregulating the entire pathway via Nrf2 activation with drugs like bardoxolone methyl.